Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001610717-25-000002
Filing Date
2025-01-02
Accepted
2025-01-02 20:33:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3575
  Complete submission text file 0001610717-25-000002.txt   5171
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Subject) CIK: 0001401667 (see all company filings)

EIN.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35703 | Film No.: 25503572
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PUMA BIOTECHNOLOGY,INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024
Business Address
HUNT DOUGLAS M (Reporting) CIK: 0001727172 (see all company filings)

Type: 144